Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Revenue

Rigel Pharmaceuticals had revenue of $101.69M in the quarter ending June 30, 2025, with 176.01% growth. This brings the company's revenue in the last twelve months to $267.92M, up 105.62% year-over-year. In the year 2024, Rigel Pharmaceuticals had annual revenue of $179.28M with 54.71% growth.

• Revenue (ttm): $267.92M
• Revenue Growth: +105.62%
• P/S Ratio: 1.90
• Revenue / Employee: $1,633,665
• Employees: 164
• Market Cap: 515.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	179.28M	63.40M	54.71%
Dec 31, 2023	115.88M	140.00K	0.12%
Dec 31, 2022	115.74M	-22.99M	-16.57%
Dec 31, 2021	138.74M	30.12M	27.72%
Dec 31, 2020	108.62M	49.33M	83.21%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.